GSK’s three-in-one inhaler gets positive opinion from EU agency

(Reuters) – GlaxoSmithKline said on Friday that a European Medicines Agency (EMA) panel has recommended the company's three-in-one inhaled lung drug.
Original Article

more recommended stories